Theravance Biopharma
TBPH
TBPH
118 hedge funds and large institutions have $552M invested in Theravance Biopharma in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 33 increasing their positions, 46 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more funds holding
Funds holding: 115 → 118 (+3)
2.34% more ownership
Funds ownership: 96.22% → 98.55% (+2.3%)
28% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 46
Holders
118
Holding in Top 10
5
Calls
$2.38M
Puts
$1K
Top Buyers
| 1 | +$3.08M | |
| 2 | +$1.82M | |
| 3 | +$1.8M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.31M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.27M |
Top Sellers
| 1 | -$12.2M | |
| 2 | -$3.93M | |
| 3 | -$2.8M | |
| 4 |
JFG
Jefferies Financial Group
New York
|
-$2.61M |
| 5 |
Millennium Management
New York
|
-$1.21M |